Diabetes mellitus and prostate cancer risk among older men: population-based case - control study

被引:41
|
作者
Coker, AL
Sanderson, M
Zheng, W
Fadden, MK
机构
[1] Univ Texas, Sch Publ Hlth, Houston, TX 77225 USA
[2] Univ Texas, Sch Publ Hlth, Brownsville, TX 78520 USA
[3] Vanderbilt Univ, Ctr Hlth Serv Res, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
关键词
prostate neoplasms; epidemiologic studies; diabetes mellitus; African-American;
D O I
10.1038/sj.bjc.6601857
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We investigate the relation between diabetes mellitus and risk of prostate cancer among older (age 65-79 years) men in a population-based case-control study of 407 incident histologically confirmed cases registered in the South Carolina Central Cancer Registry between 1999 and 2001 (70.6% response rate); controls were 393 men identified through the Health Care Financing Administration Medicare beneficiary file for South Carolina in 1999 (63.8% response rate). After adjusting for age, race, and prostate cancer screening in the past 5 years, a history of diabetes mellitus was associated with a reduced risk of prostate cancer (adjusted odds ratio (aOR) = 0.64; 95% confidence interval (CI) = 0.45, 0.91). The protective effect was stronger for those with complications associated with diabetes (aOR = 0.61; 95% CI = 0.42, 0.90) and for African-American men (aOR = 0.36; 95% CI = 0.21, 0.62). Additional research is needed to understand the biologic mechanisms by which diabetes may influence prostate cancer risk; genetic factors may play an important role in understanding this association. (C) 2004 Cancer Research UK.
引用
收藏
页码:2171 / 2175
页数:5
相关论文
共 50 条
  • [21] The risk of overt diabetes mellitus among women with gestational diabetes: a population-based study
    Savyon, M.
    DIABETIC MEDICINE, 2010, 27 (07) : 852 - 852
  • [22] Antidiabetic medication and prostate cancer risk - A population-based case-control study
    Murtola, Teemu J.
    Tammela, Teuvo L. J.
    Lahtela, Jorma
    Auvinen, Anssi
    JOURNAL OF UROLOGY, 2007, 177 (04): : 155 - 155
  • [23] Statins Increase the Risk of Prostate Cancer: A Population-Based Case-Control Study
    Chang, Chih-Ching
    Ho, Shu-Chen
    Chiu, Hui-Fen
    Yang, Chun-Yuh
    PROSTATE, 2011, 71 (16): : 1818 - 1824
  • [24] ANTIHYPERTENSIVE DRUGS AND PROSTATE CANCER RISK - A POPULATION-BASED CASE-CONTROL STUDY
    Kemppainen, K.
    Tammela, T. L. J.
    Auvinen, A.
    Murtola, T. J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 35 - 35
  • [25] Antidiabetic Medication and Prostate Cancer Risk: A population-based Case-Control Study
    Murtola, Teemu J.
    Tammela, Teuvo L. J.
    Lahtela, Jorma
    Auvinen, Anssi
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 168 (08) : 925 - 931
  • [26] Risk of dementia among persons with diabetes mellitus: A population-based cohort study
    Leibson, CL
    Rocca, WA
    Hanson, VA
    Cha, R
    Kokmen, E
    OBrien, PC
    Palumbo, PJ
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1997, 145 (04) : 301 - 308
  • [27] Cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China
    Meng Wang
    Ru-Ying Hu
    Hai-Bin Wu
    Jin Pan
    Wei-Wei Gong
    Li-Hua Guo
    Jie-Ming Zhong
    Fang-Rong Fei
    Min Yu
    Scientific Reports, 5
  • [28] Associations between depression and cancer risk among patients with diabetes mellitus: A population-based cohort study
    Wang, Shi-Heng
    Hsu, Le-Yin
    Lin, Mei-Chen
    Wu, Chi-Shin
    CANCER MEDICINE, 2023, 12 (19): : 19968 - 19977
  • [29] Cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China
    Wang, Meng
    Hu, Ru-Ying
    Wu, Hai-Bin
    Pan, Jin
    Gong, Wei-Wei
    Guo, Li-Hua
    Zhong, Jie-Ming
    Fei, Fang-Rong
    Yu, Min
    SCIENTIFIC REPORTS, 2015, 5
  • [30] Metabolic syndrome and the risk of prostate cancer in Finnish men: A population-based study
    Laukkanen, JA
    Laaksonen, DE
    Niskanen, L
    Pukkala, E
    Hakkarainen, A
    Salonen, JT
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (10) : 1646 - 1650